SuperSaturated Oxygen Comprehensive Observational Registry
(SSCORE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility and effectiveness of SuperSaturated Oxygen (SSO2) Therapy versus percutaneous coronary intervention (PCI) alone among patients with anterior acute myocardial infarction (AMI) in routine clinical practice. The goal is to collect real-world data from patients treated with SSO2 Therapy to determine its impact on the overall heart failure (HF) burden on patients and healthcare systems compared with usual care for treatment of patients with AMI. The SSCORE Registry will generate effectiveness and healthcare resource utilization data that will be used in cost-effectiveness analysis modeling.
Who Is on the Research Team?
William W O'Neill, MD
Principal Investigator
Henry Ford Hospital
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Observation
Participants are observed and data is collected on the effectiveness of SSO2 Therapy versus PCI alone
Follow-up
Participants are monitored for cardiovascular outcomes and heart failure burden
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
TherOx
Lead Sponsor